Brooke M. Katzman

Brooke M. Katzman, Ph.D., is a researcher in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science, Rochester, Minnesota. Her work focuses on clinical chemistry, immunoassay interference, and health equity in laboratory diagnostics.

• Education:
  • Postdoctoral Certificate - Advanced clinical and translational research training (2018), Mayo Graduate School of Medicine
  • Clinical Chemistry Fellow (2016), Mayo Clinic
  • Ph.D. - Organic and Medicinal Chemistry (2014), Emory University
  • BA/BS - Chemistry and Biology (2009), Youngstown State University

Her research explores analytical challenges in clinical laboratories, including biotin/vitamin interference with immunoassays, cardiovascular biomarker validation, and CXCR4 antagonists for HIV and cancer. She has published extensively on these topics and advocates for improved diagnostic protocols.

Recent publications highlight her focus on gender-affirming therapy monitoring (2025), health equity strategies (2024), and biotin interference mitigation (2019). Earlier work includes studies on NMDA receptor modulators and HIV pharmacology.

• Scientific Awards:
  • Nutrition Division Abstract Award, AACC (2018)
  • Richard Marshall Education Award, AACC Midwest Section (2016)
  • MSACL Young Investigator Travel Grant (2016)
  • Multiple student/early career awards at Youngstown State University (2009)

Katzman serves on committees for laboratory standardization, equity initiatives, and biospecimen programs. She has no listed students but collaborates widely in diagnostic research and clinical lab stewardship projects.